Minimizing the risk of reporting false positives in large-scale RNAi screens

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Christophe J. Echeverri - , Cenix BioScience GmbH (Author)
  • Philip A. Beachy - , Johns Hopkins University (Author)
  • Buzz Baum - , University of Oxford (Author)
  • Michael Boutros - , German Cancer Research Center (DKFZ) (Author)
  • Frank Buchholz - , University Cancer Centre, Chair of Medical Systems Biology, Max Planck Institute of Molecular Cell Biology and Genetics (Author)
  • Sumit K. Chanda - , Novartis AG (Author)
  • Julian Downward - , Cancer Research UK (Author)
  • Jan Ellenberg - , European Molecular Biology Laboratory (EMBL) Heidelberg (Author)
  • Andrew G. Fraser - , Wellcome Sanger Institute (Author)
  • Nir Hacohen - , Broad Institute of Harvard University and MIT, Harvard University (Author)
  • William C. Hahn - , Broad Institute of Harvard University and MIT, Dana-Farber Cancer Institute (Author)
  • Aimee L. Jackson - , Merck & Co. (Author)
  • Amy Kiger - , University of California at San Diego (Author)
  • Peter S. Linsley - , Merck & Co. (Author)
  • Lawrence Lum - , University of Texas Southwestern Medical Center (Author)
  • Yong Ma - , Johns Hopkins University (Author)
  • Bernard Mathey-Prévôt - , Harvard University (Author)
  • David E. Root - , European Molecular Biology Laboratory (EMBL) Heidelberg (Author)
  • David M. Sabatini - , European Molecular Biology Laboratory (EMBL) Heidelberg, Whitehead Institute for Biomedical Research (Author)
  • Jussi Taipale - , University of Helsinki (Author)
  • Norbert Perrimon - , Harvard University (Author)
  • René Bernards - , Netherlands Cancer Institute (Author)

Details

Original languageEnglish
Pages (from-to)777-779
Number of pages3
JournalNature methods
Volume3
Issue number10
Publication statusPublished - Oct 2006
Peer-reviewedYes

External IDs

PubMed 16990807